Current Pharmaceutical Design

Volume 7, Number 16, 1 November 2001

Links for this Journal

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016
• Ingenta Connect ISSN
• Open URL

Book Reviews

Preface
pp. i-ii(1)
Author: Bergmann-Leitner, E.S.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00001
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=i&epage=ii
• http://dx.doi.org/10.2174/1381612013397195

Reviews

New Strategy Developments in Brain Tumor Therapy
pp. 1553-1580(28)
Authors: Brandes, A.A.; Basso, U.; Pasetto, L.M.; Ermani, M.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00002
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1553&epage=1580
• http://dx.doi.org/10.2174/1381612013397221

Ras Signaling Pathway Proteins as Therapeutic Targets
pp. 1581-1594(14)
Author: Adjei, A.A.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00003
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1581&epage=1594
• http://dx.doi.org/10.2174/1381612013397258

A Prevention Strategy for Circumventing Drug Resistance in Cancer Chemotherapy
pp. 1595-1614(20)
Authors: Frenkel, G.D.; Caffrey, P.B.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00004
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1595&epage=1614
• http://dx.doi.org/10.2174/1381612013397186

Lipid Messengers as Targets for Antiangiogenic Therapy
pp. 1615-1626(12)
Authors: Robert, E.G.; Hunt, J.D.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00005
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1615&epage=1626
• http://dx.doi.org/10.2174/1381612013397203

Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity
pp. 1627-1639(13)
Author: Uckun, F.M.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00006
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1627&epage=1639
• http://dx.doi.org/10.2174/1381612013397177

Nucleic Acid for the Treatment of Cancer: Genetic Vaccines and DNA Adjuvants
pp. 1641-1667(27)
Authors: Leitner, W.W.; Hammerl, P.; Thalhamer, J.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00007
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1641&epage=1667
• http://dx.doi.org/10.2174/1381612013397249

Early Development of Cyclin Dependent Kinase Modulators
pp. 1669-1687(19)
Authors: Roy, K.K.; Sausville, E.A.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00008
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1669&epage=1687
• http://dx.doi.org/10.2174/1381612013397230

License to Kill Tumors: How Much Hope is Justified for Trail
pp. 1689-1701(13)
Authors: Frank, S.; Ebert, A.D.

Links for this article

• http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000016/art00009
• http://openurl.ingenta.com/content?genre=article&issn=1381-6128&volume=7&issue=16&spage=1689&epage=1701
• http://dx.doi.org/10.2174/1381612013397212